New milestone : Post COVID-19 irritable bowel syndrome

الحمد لله تم بحمد الله وعونه قبول بحث لى للنشر فى مجلة 

من اكثر المجلات العلمية كفاءة وتميز فى تخصص الجهاز الهضمى والكبد

I am pleased to announce that I am a coauthor for a paper titled " Post-COVID19 Irritable Bowel Syndrome," accepted for publication in the esteemed journal #gut.

Many thanks to the leader of the project, prof. Giovanni Barbara.

Impact Factor (JCR): 31.795.

Impact Factor rank (JCR): 4/93

Citescore: 40.1.

1. Trial registration number NCT04691895.

2. This article is made freely available for personal use following BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining), provided that all copyright notices and trademarks are retained.

   https://bmj.com/coronavirus/usage

   http://dx.doi.org/10.1136/gutjnl-2022-328483.

3. Request Permissions

   If you wish to reuse any or all of this article, please use the link below, which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

   Request permissions